Mechanical Circulatory Support (MCS)

Mechanical Circulatory Support (MCS) refers to the use of mechanical devices to assist or completely replace the pumping function of a failing heart. It is primarily used in patients with advanced heart failure who do not respond adequately to medications. MCS devices can be life-saving, either as a temporary bridge to recovery, a bridge to heart transplantation, or as long-term (destination) therapy.

Patients may require MCS if they experience:

  • Severe or end-stage heart failure

  • Cardiogenic shock (sudden failure of heart function)

  • Declining response to standard heart failure treatments

  • Waiting for a heart transplant (Bridge-to-Transplant)

  • Heart muscle recovery support (Bridge-to-Recovery)

  • Long-term therapy in non-transplant candidates (Destination Therapy)

When is MCS Recommended?

Types of Mechanical Circulatory Support Devices:

  • Intra-Aortic Balloon Pump (IABP):
    Temporarily supports the heart by improving blood flow to the coronary arteries and reducing the workload on the heart.

  • Left Ventricular Assist Device (LVAD):
    A surgically implanted device that helps the left ventricle pump blood to the rest of the body. Can be short-term or long-term.

  • Right Ventricular Assist Device (RVAD):
    Supports the right side of the heart, often used in combination with LVAD.

  • Biventricular Assist Device (BiVAD):
    Supports both ventricles in cases of severe biventricular heart failure.

  • Extracorporeal Membrane Oxygenation (ECMO):
    Provides both cardiac and respiratory support; commonly used in critical care settings.

Why Choose Us for Mechanical Circulatory Support?

  • Experienced Team: Led by skilled cardiac surgeons and heart failure specialists.

  • Comprehensive Infrastructure: Advanced ICU care and 24/7 monitoring systems.

  • Customized Care Plans: Tailored to individual patient needs and future goals (recovery, transplant, or long-term care).

  • Integrated Cardiac Rehabilitation: For holistic recovery post-implantation.

  • Excellent Track Record: High success rates with MCS therapies and patient satisfaction.